HomeAI · summaries
Storia in 2 fonti
Weighty Mounjaro demand helps Aspen’s 22% earnings gain
Blockbuster weight loss drug drives Aspen's commercial pharma growth
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
businessday.co.za
Weighty Mounjaro demand helps Aspen’s 22% earnings gain
Blockbuster weight loss drug drives Aspen's commercial pharma growth
- ·
africa.businessinsider.com
Mounjaro leads South Africa’s $187 million weight-loss drug boom as Aspen prepares Ozempic rival
South Africa’s GLP-1 market is approaching $187 million as Mounjaro leads sales and Aspen prepares a generic semaglutide medicine